MS Briefs

Algorithms help identify RRMS patients


 

Key clinical point: Two algorithms identified in a new study can be used for future clinical research of relapsing-remitting multiple sclerosis (RRMS). Major finding: Using EHRs and the coded health care claims of 5,308 patients with possible MS, 837 and 2,271 were identified as having RRMS, respectively. There were also 779 patients identified using both algorithms.

Study details: Two different algorithms “unstructured clinical notes (EHR clinical notes-based algorithm) and structured/coded data (claims-based algorithms)” were used to identify patients with RRMS.

Disclosures: The investigators reported no conflicts of interest.

Citation: Van Le H, et al. Value Health. 2019 Jan;22(1):77-84. doi: 10.1016/j.jval.2018.06.014 .

Recommended Reading

Cannabis-Using MS Patients Improve Cognition With 28 Days of Abstinence
ICYMI Multiple Sclerosis
Continuation of Natalizumab Treatment Reduces Risk of MS Relapses During Pregnancy
ICYMI Multiple Sclerosis
In patients with CIS, combined omics predicts conversion to clinically definite MS
ICYMI Multiple Sclerosis
Smoking impairs cognition and shrinks brain volume in MS
ICYMI Multiple Sclerosis
Adolescent lung inflammation may trigger later MS
ICYMI Multiple Sclerosis
Adolescent Lung Inflammation May Trigger Later MS
ICYMI Multiple Sclerosis
Smoking Impairs Cognition and Shrinks Brain Volume in MS
ICYMI Multiple Sclerosis
Investigators Use ARMSS Score to Predict Future MS-related Disability
ICYMI Multiple Sclerosis
FDA approves diroximel fumarate for relapsing MS
ICYMI Multiple Sclerosis
Interview with Clyde E. Markowitz, MD on switching therapies during MS treatment
ICYMI Multiple Sclerosis